About psoriasis

Conception and pregnancy: FDA determinations

The following table shows FDA-approved psoriasis treatments and their category for use by pregnant and nursing women.

Generic nameBrand nameFDA categoryComments
AcitretinSoriataneX

Causes birth defects. Absolutely avoid.

AdalimumabHumiraB

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

AlefaceptAmeviveB

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Anthralin  C

No clear evidence of birth defects. Avoid unless necessary.

CalcipotrieneDovonex C

No clear evidence of birth defects. Avoid unless necessary.

Calcipotriene
and
betamethasone
dipropionate
Taclonex C

No clear evidence of birth defects. Avoid unless necessary.

CalcitriolVectical ointment C

No clear evidence of birth defects. Avoid unless necessary.

Cyclosporine  C

No clear evidence of birth defects. Avoid unless necessary.

EfalizumabRaptiva C

No clear evidence of birth defects. Avoid unless necessary. On April 8, 2009, Genentech, Inc. announced a voluntary withdrawal of Raptiva from the U.S. Market, this drug is no longer available. Please contact your dermatologist for further information.

EtanerceptEnbrel B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

InfliximabRemicade B

Long-term animal studies showed no harm. No human studies conducted. Avoid unless necessary.

Methotrexate  X

Even small doses can cause defects in first trimester. Absolutely avoid.

PUVA  C

No clear evidence of birth defects, although PUVA affects DNA. Avoid unless necessary.

TazaroteneTazorac X

Risk of internal absorption. Absolutely avoid.

Topical steroids  C

No clear evidence of birth defects. Avoid unless necessary.

UVB 

Safe during pregnancy. May cause skin discoloration.

Key to FDA categories

B

Studies with animals have not found risk to the fetus but no studies have been done in humans.

CSafety is not substantiated by animal or human studies.
XRisk in pregnancy outweighs any benefits
LearnAct
ConnectCure

Share